Spatial Biology – News and Features

Scientists have discovered that the microenvironment supporting cancer tumors starves immune cells of 'fuel', preventing tumour destruction.

Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.

Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.

‘Antigen-presenting cell’ activates T cells by alerting them to the presence of tumors.

Clinical trial will test safety of new strategy in patients with advanced pancreatic tumors.

This approval is a testament to CGI’s ability to provide NGS panels that meet the highest quality standards.

Agreement is the latest in a series of acquisitions and strategic collaborations that have bolstered Novartis' deep and diverse immuno-oncology pipeline.

Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.

Cancer cells appear to depend on an unusual survival mechanism to spread around the body, according to an early study led by Queen Mary University of London.

Phasefocus have recently launched Livecyte™ for immunological, neurobiological, cancer and basic cell biology research.